17:28 EST Solid Biosciences (SLDB) gains 12% to $4.40 on FDA clearance of SGT-212 IND
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLDB:
- Solid Biosciences announces FDA clearance of SGT-212 IND application
- Solid Biosciences reports inducement grants under Nasdaq listing rule
- Closing Bell Movers: International Seaways up 8% on S&P600 inclusion
- Solid Biosciences added to Nasdaq Biotechnology Index
- Wedbush starts Solid Biosciences at Outperform on ‘potentially better’ DMD tool